Himalaya is a majority owned subsidiary of BioAtla, Inc. and a Cayman Island corporation. Himalaya has the exclusive license from BioAtla to develop and commercialize several specific CAB candidates for the Greater China market of the PRC,

Biotechnology

Himalaya Therapeutics

Himalaya Therapeutics' headquarters in George Town, Cayman Islands

Brian Zhang

Howe Li

Carolyn Short

Nicholas Desjardins

Jay Short

Scott Smith

Clark Randt Jr.

James Allison

Richard Waldron

Padmanee Sharma

Tan Xiangdong

Lawrence Steinman

The Leadership Team at Himalaya Therapeutics drives the strategic vision and operational execution for the development and commercialization of specialized CAB candidates in the Greater China market. This team oversees critical functions such as medical strategy, financial planning, and corporate development, ensuring alignment with BioAtla's objectives while fostering innovation and regulatory compliance within the biopharmaceutical landscape. Through collaborative leadership, they aim to enhance patient access to novel therapies in a rapidly evolving market.

Leadership Team

The Advisory Team at Himalaya Therapeutics provides strategic guidance and expert insights to aid in the development and commercialization of CAB candidates in the Greater China market. Comprised of seasoned advisors, the team leverages their industry expertise to inform key decisions, navigate regulatory landscapes, and enhance market positioning, ensuring successful product launches and partnerships.

Advisory Team

��

Himalaya Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Advisory Team

Offices

��������

Himalaya Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Advisory Team

Offices

Related companies

��